Age Differences in Acute Chest Pain Care in a Multisite US Cohort

美国多中心队列研究中急性胸痛治疗的年龄差异

阅读:3

Abstract

BACKGROUND: This study aims to determine if differences in age affect safety and healthcare utilization among patients with chest pain in a multisite US ED cohort, after accounting for comorbidities and high-sensitivity troponin (hs-cTn). METHODS: We conducted a multisite observational study using the Wake Forest Chest Pain Registry, which included patients ≥ 18 years old with chest pain across 25 EDs (01/01/2021 to 12/31/2021). Each site used an hs-cTn chest pain protocol. Patients were categorized as older (≥ 65 years), middle-aged (46-64 years), or young (18-45 years). The primary safety outcome was death or MI at 30 days. The primary healthcare utilization outcome was 30-day hospitalization. Multivariable logistic regression models assessed the association between age and outcomes, adjusting for sex, race, ethnicity, obesity, smoking, rurality, coronary disease, diabetes, hypertension, hyperlipidemia, insurance, site, and hs-cTn, with young patients as the reference. RESULTS: Among 40 979 patients, 25.1% were older, 39.7% middle-aged, and 35.2% young. At 30 days, death or MI occurred in 7.3% (750/10 298) of older, 3.8% (611/16 260) of middle-aged, and 0.8% (108/14 421) of young patients. After adjustment, death or MI at 30 days was more common among older (aOR 1.57, 95% CI 1.17-2.12) and middle-aged (aOR 1.57, 95% CI 1.22-2.02) patients. Hospitalization at 30 days occurred in 56.3% (5799/10 298) of older, 35.4% (5761/16 260) of middle-aged, and 12.8% (1849/14 421) of young patients. With adjustment, hospitalization remained more common among older (aOR 2.51, 95% CI 2.27-2.78) and middle-aged (aOR 1.93, 95% CI 1.80-2.07) patients. CONCLUSION: After adjusting for comorbidities and hs-cTn results, older adults had higher rates of death or MI and hospitalization at 30 days.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。